aluates Reports

$ 0.0

Automative

Global Graft Versus Host Disease Treatment Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-9J10693

Global Graft Versus Host Disease Treatment Market Research Report 2022

BUY CHAPTERS

Global Graft Versus Host Disease Treatment Market Research Report 2025

Code: QYRE-Auto-9J10693

Report

March 2025

Pages:94

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AbbVie

Astellas Pharma Inc

Bristol Myers Squibb Company

F. Hoffmann-La Roche AG

Johnson & Johnson

Merck& Co. Inc

Mesoblast Limited

Neovii Biotech GmbH

Novartis

Ocugen

Pfizer Inc

Pluristem Therapeutics Inc

Sanofi SA

Soligenix Inc

Acrofan

ElsaLys Biotech SA

Mallinckrodft PLC

Samedan Ltd

Graft Versus Host Disease Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Graft Versus Host Disease Treatment Market

The global market for Graft Versus Host Disease Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Graft Versus Host Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Graft Versus Host Disease Treatment.

The Graft Versus Host Disease Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Graft Versus Host Disease Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Graft Versus Host Disease Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Graft Versus Host Disease Treatment Market Report

Report Metric	Details
Report Name	Graft Versus Host Disease Treatment Market
CAGR	5%
Segment by Type	Etanercept Monoclonal Antibodies Thalidomide Tyrosine Kinase Inhibitors mTOR Inhibitors
Segment by Application	Acute GVHD Chronic GVHD Prophylaxis GVHD
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie Inc., Acrofan, Astellas Pharma Inc., Bristol-Myers Squibb Company, ElsaLys Biotech SA, F. Hoffmann-La Roche AG, Johnson & Johnson, Mallinckrodft PLC, Merck & Co., Inc., Mesoblast Limited, Neovii Biotech GmbH, Novartis AG, Ocugen, Inc., Pfizer Inc, Pluristem Therapeutics Inc., Samedan Ltd, Sanofi SA, Soligenix, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Graft Versus Host Disease Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Graft Versus Host Disease Treatment Market report?

Ans: The main players in the Graft Versus Host Disease Treatment Market are AbbVie Inc., Acrofan, Astellas Pharma Inc., Bristol-Myers Squibb Company, ElsaLys Biotech SA, F. Hoffmann-La Roche AG, Johnson & Johnson, Mallinckrodft PLC, Merck & Co., Inc., Mesoblast Limited, Neovii Biotech GmbH, Novartis AG, Ocugen, Inc., Pfizer Inc, Pluristem Therapeutics Inc., Samedan Ltd, Sanofi SA, Soligenix, Inc.

What are the Application segmentation covered in the Graft Versus Host Disease Treatment Market report?

Ans: The Applications covered in the Graft Versus Host Disease Treatment Market report are Acute GVHD, Chronic GVHD, Prophylaxis GVHD

What are the Type segmentation covered in the Graft Versus Host Disease Treatment Market report?

Ans: The Types covered in the Graft Versus Host Disease Treatment Market report are Etanercept, Monoclonal Antibodies, Thalidomide, Tyrosine Kinase Inhibitors, mTOR Inhibitors

Recommended Reports

Cell and Gene Therapy

Cancer & Lymphoma Treatment

Therapeutics & Immunotherapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Graft Versus Host Disease Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Etanercept

1.2.3 Monoclonal Antibodies

1.2.4 Thalidomide

1.2.5 Tyrosine Kinase Inhibitors

1.2.6 mTOR Inhibitors

1.3 Market by Application

1.3.1 Global Graft Versus Host Disease Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Acute GVHD

1.3.3 Chronic GVHD

1.3.4 Prophylaxis GVHD

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Graft Versus Host Disease Treatment Market Perspective (2020-2031)

2.2 Global Graft Versus Host Disease Treatment Growth Trends by Region

2.2.1 Global Graft Versus Host Disease Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Graft Versus Host Disease Treatment Historic Market Size by Region (2020-2025)

2.2.3 Graft Versus Host Disease Treatment Forecasted Market Size by Region (2026-2031)

2.3 Graft Versus Host Disease Treatment Market Dynamics

2.3.1 Graft Versus Host Disease Treatment Industry Trends

2.3.2 Graft Versus Host Disease Treatment Market Drivers

2.3.3 Graft Versus Host Disease Treatment Market Challenges

2.3.4 Graft Versus Host Disease Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Graft Versus Host Disease Treatment Players by Revenue

3.1.1 Global Top Graft Versus Host Disease Treatment Players by Revenue (2020-2025)

3.1.2 Global Graft Versus Host Disease Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Graft Versus Host Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Graft Versus Host Disease Treatment Revenue

3.4 Global Graft Versus Host Disease Treatment Market Concentration Ratio

3.4.1 Global Graft Versus Host Disease Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Graft Versus Host Disease Treatment Revenue in 2024

3.5 Global Key Players of Graft Versus Host Disease Treatment Head office and Area Served

3.6 Global Key Players of Graft Versus Host Disease Treatment, Product and Application

3.7 Global Key Players of Graft Versus Host Disease Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Graft Versus Host Disease Treatment Breakdown Data by Type

4.1 Global Graft Versus Host Disease Treatment Historic Market Size by Type (2020-2025)

4.2 Global Graft Versus Host Disease Treatment Forecasted Market Size by Type (2026-2031)

5 Graft Versus Host Disease Treatment Breakdown Data by Application

5.1 Global Graft Versus Host Disease Treatment Historic Market Size by Application (2020-2025)

5.2 Global Graft Versus Host Disease Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Graft Versus Host Disease Treatment Market Size (2020-2031)

6.2 North America Graft Versus Host Disease Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Graft Versus Host Disease Treatment Market Size by Country (2020-2025)

6.4 North America Graft Versus Host Disease Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Graft Versus Host Disease Treatment Market Size (2020-2031)

7.2 Europe Graft Versus Host Disease Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Graft Versus Host Disease Treatment Market Size by Country (2020-2025)

7.4 Europe Graft Versus Host Disease Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Graft Versus Host Disease Treatment Market Size (2020-2031)

8.2 Asia-Pacific Graft Versus Host Disease Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Graft Versus Host Disease Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Graft Versus Host Disease Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Graft Versus Host Disease Treatment Market Size (2020-2031)

9.2 Latin America Graft Versus Host Disease Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Graft Versus Host Disease Treatment Market Size by Country (2020-2025)

9.4 Latin America Graft Versus Host Disease Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Graft Versus Host Disease Treatment Market Size (2020-2031)

10.2 Middle East & Africa Graft Versus Host Disease Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Graft Versus Host Disease Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Graft Versus Host Disease Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AbbVie Inc.

11.1.1 AbbVie Inc. Company Details

11.1.2 AbbVie Inc. Business Overview

11.1.3 AbbVie Inc. Graft Versus Host Disease Treatment Introduction

11.1.4 AbbVie Inc. Revenue in Graft Versus Host Disease Treatment Business (2020-2025)

11.1.5 AbbVie Inc. Recent Development

11.2 Acrofan

11.2.1 Acrofan Company Details

11.2.2 Acrofan Business Overview

11.2.3 Acrofan Graft Versus Host Disease Treatment Introduction

11.2.4 Acrofan Revenue in Graft Versus Host Disease Treatment Business (2020-2025)

11.2.5 Acrofan Recent Development

11.3 Astellas Pharma Inc.

11.3.1 Astellas Pharma Inc. Company Details

11.3.2 Astellas Pharma Inc. Business Overview

11.3.3 Astellas Pharma Inc. Graft Versus Host Disease Treatment Introduction

11.3.4 Astellas Pharma Inc. Revenue in Graft Versus Host Disease Treatment Business (2020-2025)

11.3.5 Astellas Pharma Inc. Recent Development

11.4 Bristol-Myers Squibb Company

11.4.1 Bristol-Myers Squibb Company Company Details

11.4.2 Bristol-Myers Squibb Company Business Overview

11.4.3 Bristol-Myers Squibb Company Graft Versus Host Disease Treatment Introduction

11.4.4 Bristol-Myers Squibb Company Revenue in Graft Versus Host Disease Treatment Business (2020-2025)

11.4.5 Bristol-Myers Squibb Company Recent Development

11.5 ElsaLys Biotech SA

11.5.1 ElsaLys Biotech SA Company Details

11.5.2 ElsaLys Biotech SA Business Overview

11.5.3 ElsaLys Biotech SA Graft Versus Host Disease Treatment Introduction

11.5.4 ElsaLys Biotech SA Revenue in Graft Versus Host Disease Treatment Business (2020-2025)

11.5.5 ElsaLys Biotech SA Recent Development

11.6 F. Hoffmann-La Roche AG

11.6.1 F. Hoffmann-La Roche AG Company Details

11.6.2 F. Hoffmann-La Roche AG Business Overview

11.6.3 F. Hoffmann-La Roche AG Graft Versus Host Disease Treatment Introduction

11.6.4 F. Hoffmann-La Roche AG Revenue in Graft Versus Host Disease Treatment Business (2020-2025)

11.6.5 F. Hoffmann-La Roche AG Recent Development

11.7 Johnson & Johnson

11.7.1 Johnson & Johnson Company Details

11.7.2 Johnson & Johnson Business Overview

11.7.3 Johnson & Johnson Graft Versus Host Disease Treatment Introduction

11.7.4 Johnson & Johnson Revenue in Graft Versus Host Disease Treatment Business (2020-2025)

11.7.5 Johnson & Johnson Recent Development

11.8 Mallinckrodft PLC

11.8.1 Mallinckrodft PLC Company Details

11.8.2 Mallinckrodft PLC Business Overview

11.8.3 Mallinckrodft PLC Graft Versus Host Disease Treatment Introduction

11.8.4 Mallinckrodft PLC Revenue in Graft Versus Host Disease Treatment Business (2020-2025)

11.8.5 Mallinckrodft PLC Recent Development

11.9 Merck & Co., Inc.

11.9.1 Merck & Co., Inc. Company Details

11.9.2 Merck & Co., Inc. Business Overview

11.9.3 Merck & Co., Inc. Graft Versus Host Disease Treatment Introduction

11.9.4 Merck & Co., Inc. Revenue in Graft Versus Host Disease Treatment Business (2020-2025)

11.9.5 Merck & Co., Inc. Recent Development

11.10 Mesoblast Limited

11.10.1 Mesoblast Limited Company Details

11.10.2 Mesoblast Limited Business Overview

11.10.3 Mesoblast Limited Graft Versus Host Disease Treatment Introduction

11.10.4 Mesoblast Limited Revenue in Graft Versus Host Disease Treatment Business (2020-2025)

11.10.5 Mesoblast Limited Recent Development

11.11 Neovii Biotech GmbH

11.11.1 Neovii Biotech GmbH Company Details

11.11.2 Neovii Biotech GmbH Business Overview

11.11.3 Neovii Biotech GmbH Graft Versus Host Disease Treatment Introduction

11.11.4 Neovii Biotech GmbH Revenue in Graft Versus Host Disease Treatment Business (2020-2025)

11.11.5 Neovii Biotech GmbH Recent Development

11.12 Novartis AG

11.12.1 Novartis AG Company Details

11.12.2 Novartis AG Business Overview

11.12.3 Novartis AG Graft Versus Host Disease Treatment Introduction

11.12.4 Novartis AG Revenue in Graft Versus Host Disease Treatment Business (2020-2025)

11.12.5 Novartis AG Recent Development

11.13 Ocugen, Inc.

11.13.1 Ocugen, Inc. Company Details

11.13.2 Ocugen, Inc. Business Overview

11.13.3 Ocugen, Inc. Graft Versus Host Disease Treatment Introduction

11.13.4 Ocugen, Inc. Revenue in Graft Versus Host Disease Treatment Business (2020-2025)

11.13.5 Ocugen, Inc. Recent Development

11.14 Pfizer Inc

11.14.1 Pfizer Inc Company Details

11.14.2 Pfizer Inc Business Overview

11.14.3 Pfizer Inc Graft Versus Host Disease Treatment Introduction

11.14.4 Pfizer Inc Revenue in Graft Versus Host Disease Treatment Business (2020-2025)

11.14.5 Pfizer Inc Recent Development

11.15 Pluristem Therapeutics Inc.

11.15.1 Pluristem Therapeutics Inc. Company Details

11.15.2 Pluristem Therapeutics Inc. Business Overview

11.15.3 Pluristem Therapeutics Inc. Graft Versus Host Disease Treatment Introduction

11.15.4 Pluristem Therapeutics Inc. Revenue in Graft Versus Host Disease Treatment Business (2020-2025)

11.15.5 Pluristem Therapeutics Inc. Recent Development

11.16 Samedan Ltd

11.16.1 Samedan Ltd Company Details

11.16.2 Samedan Ltd Business Overview

11.16.3 Samedan Ltd Graft Versus Host Disease Treatment Introduction

11.16.4 Samedan Ltd Revenue in Graft Versus Host Disease Treatment Business (2020-2025)

11.16.5 Samedan Ltd Recent Development

11.17 Sanofi SA

11.17.1 Sanofi SA Company Details

11.17.2 Sanofi SA Business Overview

11.17.3 Sanofi SA Graft Versus Host Disease Treatment Introduction

11.17.4 Sanofi SA Revenue in Graft Versus Host Disease Treatment Business (2020-2025)

11.17.5 Sanofi SA Recent Development

11.18 Soligenix, Inc.

11.18.1 Soligenix, Inc. Company Details

11.18.2 Soligenix, Inc. Business Overview

11.18.3 Soligenix, Inc. Graft Versus Host Disease Treatment Introduction

11.18.4 Soligenix, Inc. Revenue in Graft Versus Host Disease Treatment Business (2020-2025)

11.18.5 Soligenix, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

AbbVie

Astellas Pharma Inc

Bristol Myers Squibb Company

F. Hoffmann-La Roche AG

Johnson & Johnson

Merck& Co. Inc

Mesoblast Limited

Neovii Biotech GmbH

Novartis

Ocugen

Pfizer Inc

Pluristem Therapeutics Inc

Sanofi SA

Soligenix Inc

Acrofan

ElsaLys Biotech SA

Mallinckrodft PLC

Samedan Ltd

List of Tables

Table 1. Global Graft Versus Host Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Etanercept

Table 3. Key Players of Monoclonal Antibodies

Table 4. Key Players of Thalidomide

Table 5. Key Players of Tyrosine Kinase Inhibitors

Table 6. Key Players of mTOR Inhibitors

Table 7. Global Graft Versus Host Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Graft Versus Host Disease Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Graft Versus Host Disease Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Graft Versus Host Disease Treatment Market Share by Region (2020-2025)

Table 11. Global Graft Versus Host Disease Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Graft Versus Host Disease Treatment Market Share by Region (2026-2031)

Table 13. Graft Versus Host Disease Treatment Market Trends

Table 14. Graft Versus Host Disease Treatment Market Drivers

Table 15. Graft Versus Host Disease Treatment Market Challenges

Table 16. Graft Versus Host Disease Treatment Market Restraints

Table 17. Global Graft Versus Host Disease Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Graft Versus Host Disease Treatment Market Share by Players (2020-2025)

Table 19. Global Top Graft Versus Host Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Graft Versus Host Disease Treatment as of 2024)

Table 20. Ranking of Global Top Graft Versus Host Disease Treatment Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Graft Versus Host Disease Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Graft Versus Host Disease Treatment, Headquarters and Area Served

Table 23. Global Key Players of Graft Versus Host Disease Treatment, Product and Application

Table 24. Global Key Players of Graft Versus Host Disease Treatment, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Graft Versus Host Disease Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Graft Versus Host Disease Treatment Revenue Market Share by Type (2020-2025)

Table 28. Global Graft Versus Host Disease Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Graft Versus Host Disease Treatment Revenue Market Share by Type (2026-2031)

Table 30. Global Graft Versus Host Disease Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Graft Versus Host Disease Treatment Revenue Market Share by Application (2020-2025)

Table 32. Global Graft Versus Host Disease Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Graft Versus Host Disease Treatment Revenue Market Share by Application (2026-2031)

Table 34. North America Graft Versus Host Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Graft Versus Host Disease Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Graft Versus Host Disease Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Graft Versus Host Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Graft Versus Host Disease Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Graft Versus Host Disease Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Graft Versus Host Disease Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Graft Versus Host Disease Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Graft Versus Host Disease Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Graft Versus Host Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Graft Versus Host Disease Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Graft Versus Host Disease Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Graft Versus Host Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Graft Versus Host Disease Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Graft Versus Host Disease Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 49. AbbVie Inc. Company Details

Table 50. AbbVie Inc. Business Overview

Table 51. AbbVie Inc. Graft Versus Host Disease Treatment Product

Table 52. AbbVie Inc. Revenue in Graft Versus Host Disease Treatment Business (2020-2025) & (US$ Million)

Table 53. AbbVie Inc. Recent Development

Table 54. Acrofan Company Details

Table 55. Acrofan Business Overview

Table 56. Acrofan Graft Versus Host Disease Treatment Product

Table 57. Acrofan Revenue in Graft Versus Host Disease Treatment Business (2020-2025) & (US$ Million)

Table 58. Acrofan Recent Development

Table 59. Astellas Pharma Inc. Company Details

Table 60. Astellas Pharma Inc. Business Overview

Table 61. Astellas Pharma Inc. Graft Versus Host Disease Treatment Product

Table 62. Astellas Pharma Inc. Revenue in Graft Versus Host Disease Treatment Business (2020-2025) & (US$ Million)

Table 63. Astellas Pharma Inc. Recent Development

Table 64. Bristol-Myers Squibb Company Company Details

Table 65. Bristol-Myers Squibb Company Business Overview

Table 66. Bristol-Myers Squibb Company Graft Versus Host Disease Treatment Product

Table 67. Bristol-Myers Squibb Company Revenue in Graft Versus Host Disease Treatment Business (2020-2025) & (US$ Million)

Table 68. Bristol-Myers Squibb Company Recent Development

Table 69. ElsaLys Biotech SA Company Details

Table 70. ElsaLys Biotech SA Business Overview

Table 71. ElsaLys Biotech SA Graft Versus Host Disease Treatment Product

Table 72. ElsaLys Biotech SA Revenue in Graft Versus Host Disease Treatment Business (2020-2025) & (US$ Million)

Table 73. ElsaLys Biotech SA Recent Development

Table 74. F. Hoffmann-La Roche AG Company Details

Table 75. F. Hoffmann-La Roche AG Business Overview

Table 76. F. Hoffmann-La Roche AG Graft Versus Host Disease Treatment Product

Table 77. F. Hoffmann-La Roche AG Revenue in Graft Versus Host Disease Treatment Business (2020-2025) & (US$ Million)

Table 78. F. Hoffmann-La Roche AG Recent Development

Table 79. Johnson & Johnson Company Details

Table 80. Johnson & Johnson Business Overview

Table 81. Johnson & Johnson Graft Versus Host Disease Treatment Product

Table 82. Johnson & Johnson Revenue in Graft Versus Host Disease Treatment Business (2020-2025) & (US$ Million)

Table 83. Johnson & Johnson Recent Development

Table 84. Mallinckrodft PLC Company Details

Table 85. Mallinckrodft PLC Business Overview

Table 86. Mallinckrodft PLC Graft Versus Host Disease Treatment Product

Table 87. Mallinckrodft PLC Revenue in Graft Versus Host Disease Treatment Business (2020-2025) & (US$ Million)

Table 88. Mallinckrodft PLC Recent Development

Table 89. Merck & Co., Inc. Company Details

Table 90. Merck & Co., Inc. Business Overview

Table 91. Merck & Co., Inc. Graft Versus Host Disease Treatment Product

Table 92. Merck & Co., Inc. Revenue in Graft Versus Host Disease Treatment Business (2020-2025) & (US$ Million)

Table 93. Merck & Co., Inc. Recent Development

Table 94. Mesoblast Limited Company Details

Table 95. Mesoblast Limited Business Overview

Table 96. Mesoblast Limited Graft Versus Host Disease Treatment Product

Table 97. Mesoblast Limited Revenue in Graft Versus Host Disease Treatment Business (2020-2025) & (US$ Million)

Table 98. Mesoblast Limited Recent Development

Table 99. Neovii Biotech GmbH Company Details

Table 100. Neovii Biotech GmbH Business Overview

Table 101. Neovii Biotech GmbH Graft Versus Host Disease Treatment Product

Table 102. Neovii Biotech GmbH Revenue in Graft Versus Host Disease Treatment Business (2020-2025) & (US$ Million)

Table 103. Neovii Biotech GmbH Recent Development

Table 104. Novartis AG Company Details

Table 105. Novartis AG Business Overview

Table 106. Novartis AG Graft Versus Host Disease Treatment Product

Table 107. Novartis AG Revenue in Graft Versus Host Disease Treatment Business (2020-2025) & (US$ Million)

Table 108. Novartis AG Recent Development

Table 109. Ocugen, Inc. Company Details

Table 110. Ocugen, Inc. Business Overview

Table 111. Ocugen, Inc. Graft Versus Host Disease Treatment Product

Table 112. Ocugen, Inc. Revenue in Graft Versus Host Disease Treatment Business (2020-2025) & (US$ Million)

Table 113. Ocugen, Inc. Recent Development

Table 114. Pfizer Inc Company Details

Table 115. Pfizer Inc Business Overview

Table 116. Pfizer Inc Graft Versus Host Disease Treatment Product

Table 117. Pfizer Inc Revenue in Graft Versus Host Disease Treatment Business (2020-2025) & (US$ Million)

Table 118. Pfizer Inc Recent Development

Table 119. Pluristem Therapeutics Inc. Company Details

Table 120. Pluristem Therapeutics Inc. Business Overview

Table 121. Pluristem Therapeutics Inc. Graft Versus Host Disease Treatment Product

Table 122. Pluristem Therapeutics Inc. Revenue in Graft Versus Host Disease Treatment Business (2020-2025) & (US$ Million)

Table 123. Pluristem Therapeutics Inc. Recent Development

Table 124. Samedan Ltd Company Details

Table 125. Samedan Ltd Business Overview

Table 126. Samedan Ltd Graft Versus Host Disease Treatment Product

Table 127. Samedan Ltd Revenue in Graft Versus Host Disease Treatment Business (2020-2025) & (US$ Million)

Table 128. Samedan Ltd Recent Development

Table 129. Sanofi SA Company Details

Table 130. Sanofi SA Business Overview

Table 131. Sanofi SA Graft Versus Host Disease Treatment Product

Table 132. Sanofi SA Revenue in Graft Versus Host Disease Treatment Business (2020-2025) & (US$ Million)

Table 133. Sanofi SA Recent Development

Table 134. Soligenix, Inc. Company Details

Table 135. Soligenix, Inc. Business Overview

Table 136. Soligenix, Inc. Graft Versus Host Disease Treatment Product

Table 137. Soligenix, Inc. Revenue in Graft Versus Host Disease Treatment Business (2020-2025) & (US$ Million)

Table 138. Soligenix, Inc. Recent Development

Table 139. Research Programs/Design for This Report

Table 140. Key Data Information from Secondary Sources

Table 141. Key Data Information from Primary Sources

Table 142. Authors List of This Report

List of Figures

Figure 1. Graft Versus Host Disease Treatment Picture

Figure 2. Global Graft Versus Host Disease Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Graft Versus Host Disease Treatment Market Share by Type: 2024 VS 2031

Figure 4. Etanercept Features

Figure 5. Monoclonal Antibodies Features

Figure 6. Thalidomide Features

Figure 7. Tyrosine Kinase Inhibitors Features

Figure 8. mTOR Inhibitors Features

Figure 9. Global Graft Versus Host Disease Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Graft Versus Host Disease Treatment Market Share by Application: 2024 VS 2031

Figure 11. Acute GVHD Case Studies

Figure 12. Chronic GVHD Case Studies

Figure 13. Prophylaxis GVHD Case Studies

Figure 14. Graft Versus Host Disease Treatment Report Years Considered

Figure 15. Global Graft Versus Host Disease Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Graft Versus Host Disease Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Graft Versus Host Disease Treatment Market Share by Region: 2024 VS 2031

Figure 18. Global Graft Versus Host Disease Treatment Market Share by Players in 2024

Figure 19. Global Top Graft Versus Host Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Graft Versus Host Disease Treatment as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Graft Versus Host Disease Treatment Revenue in 2024

Figure 21. North America Graft Versus Host Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Graft Versus Host Disease Treatment Market Share by Country (2020-2031)

Figure 23. United States Graft Versus Host Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Graft Versus Host Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Graft Versus Host Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Graft Versus Host Disease Treatment Market Share by Country (2020-2031)

Figure 27. Germany Graft Versus Host Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Graft Versus Host Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Graft Versus Host Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Graft Versus Host Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Graft Versus Host Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Graft Versus Host Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Graft Versus Host Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Graft Versus Host Disease Treatment Market Share by Region (2020-2031)

Figure 35. China Graft Versus Host Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Graft Versus Host Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Graft Versus Host Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Graft Versus Host Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Graft Versus Host Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Graft Versus Host Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Graft Versus Host Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Graft Versus Host Disease Treatment Market Share by Country (2020-2031)

Figure 43. Mexico Graft Versus Host Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Graft Versus Host Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Graft Versus Host Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Graft Versus Host Disease Treatment Market Share by Country (2020-2031)

Figure 47. Turkey Graft Versus Host Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Graft Versus Host Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Graft Versus Host Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. AbbVie Inc. Revenue Growth Rate in Graft Versus Host Disease Treatment Business (2020-2025)

Figure 51. Acrofan Revenue Growth Rate in Graft Versus Host Disease Treatment Business (2020-2025)

Figure 52. Astellas Pharma Inc. Revenue Growth Rate in Graft Versus Host Disease Treatment Business (2020-2025)

Figure 53. Bristol-Myers Squibb Company Revenue Growth Rate in Graft Versus Host Disease Treatment Business (2020-2025)

Figure 54. ElsaLys Biotech SA Revenue Growth Rate in Graft Versus Host Disease Treatment Business (2020-2025)

Figure 55. F. Hoffmann-La Roche AG Revenue Growth Rate in Graft Versus Host Disease Treatment Business (2020-2025)

Figure 56. Johnson & Johnson Revenue Growth Rate in Graft Versus Host Disease Treatment Business (2020-2025)

Figure 57. Mallinckrodft PLC Revenue Growth Rate in Graft Versus Host Disease Treatment Business (2020-2025)

Figure 58. Merck & Co., Inc. Revenue Growth Rate in Graft Versus Host Disease Treatment Business (2020-2025)

Figure 59. Mesoblast Limited Revenue Growth Rate in Graft Versus Host Disease Treatment Business (2020-2025)

Figure 60. Neovii Biotech GmbH Revenue Growth Rate in Graft Versus Host Disease Treatment Business (2020-2025)

Figure 61. Novartis AG Revenue Growth Rate in Graft Versus Host Disease Treatment Business (2020-2025)

Figure 62. Ocugen, Inc. Revenue Growth Rate in Graft Versus Host Disease Treatment Business (2020-2025)

Figure 63. Pfizer Inc Revenue Growth Rate in Graft Versus Host Disease Treatment Business (2020-2025)

Figure 64. Pluristem Therapeutics Inc. Revenue Growth Rate in Graft Versus Host Disease Treatment Business (2020-2025)

Figure 65. Samedan Ltd Revenue Growth Rate in Graft Versus Host Disease Treatment Business (2020-2025)

Figure 66. Sanofi SA Revenue Growth Rate in Graft Versus Host Disease Treatment Business (2020-2025)

Figure 67. Soligenix, Inc. Revenue Growth Rate in Graft Versus Host Disease Treatment Business (2020-2025)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Cancer Stem Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cell Therapy Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Therapeutics and Biotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hematological Malignancies Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Scar Removal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hematological Malignancies Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Next Generation Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancers Immunotherapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lymphoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Thymus Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Clinical Trials of Drugs and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Autologous Stem Cell and Non Stem Cell Based Therapies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Inflammatory Bowel Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cardiovascular Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Stem Cell Hair Transplant Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Next Generation Immunology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drug Delivery Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions